Scientific publications

Splenic embolization prior to myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis

Bilbao JI, Sangro B, Longo JM, Zozaya JM, Fernández-Virgós A, Aquerreta JD [SP], Beloqui O, Prieto J.
Department of Radiology, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra, Pamplona, Spain.

Magazine: European Journal of Radiology

Date: Sep 30, 1992

Hepatology Radiology [SP]

In the treatment of active chronic hepatitis and hepatocellular carcinoma some effective drugs can produce myelosuppression. Hypersplenism may considerably limit the dosage of such drugs. Splenectomy is an effective treatment for hypersplenism, although it is not without complications.

Partial splenic embolization is a good and safe procedure; 15 patients were treated in order to achieve higher platelet and leukocyte counts. Embolization has been performed with gelfoam with local and systemic antibiotics (Spigos' protocol) and 50-75% of the splenic parenchyma was infarcted.

All patients could be treated for the underlying hepatopathy with adequate dosages of interferon or chemotherapeutic drugs.

CITATION  Eur J Radiol. 1992 Oct;15(3):211-4

you maybe interested

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra